Zimmer Biomet Holdings, Inc. (BIT:1ZBH)

Market Cap	13.73B -21.4%
Revenue (ttm)	7.29B +9.2%
Net Income	660.19M -16.7%
EPS	3.34 -14.4%
Shares Out	n/a
PE Ratio	20.80
Forward PE	9.72
Dividend	0.62 (0.86%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Open	67.72
Previous Close	67.72
Day's Range	67.72 - 67.72
52-Week Range	67.72 - 94.94
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 28, 2026

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well a...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1927
• Employees: 17,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1ZBH

Financial Performance

In 2025, Zimmer Biomet Holdings's revenue was $8.23 billion, an increase of 7.20% compared to the previous year's $7.68 billion. Earnings were $705.10 million, a decrease of -21.98%.

Financial numbers in USD